Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Creo Medical Group "gaining a level of acceptance" in endoscopy

Creo Medical Group "gaining a level of acceptance" in endoscopy

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive about the latest developments at the medical device company, following a successful appearance at Digestive Disease Week.

Gulliford says that Creo Medical is "gaining a level of acceptance" both within its home market the UK and beyond, highlighting increasing interest from the burgeoning Asian market.